Danaher Corporation vs Global E Online Ltd — how do they compare? Danaher Corporation trades at $200.98 (market cap $140.88B), while Global E Online Ltd trades at $39.08 (market cap $6.51B). The key difference: Danaher Corporation is far larger — about 21.6× Global E Online Ltd's market cap, and Danaher Corporation pays a 0.8% dividend while Global E Online Ltd pays none. Which is the better fit depends on your goals.
| DHR | GLBE | |
|---|---|---|
Market Cap | $140.88B | $6.51B |
Sector | Health | Technology |
52-Week High | $242.05 | $41.59 |
52-Week Low | $161.91 | $27.54 |
Enterprise Value | $153.66B | $5.98B |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
GLBE trades at $38.68, up 0.52% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong Q1 2026 results with revenue growth of 33% year-over-year and raised full-year guidance, achieving a 'Rule of 50' metric. Recent acquisition of Passport enhances logistics capabilities, supporting future growth. Valuation remains elevated with a P/E of 57.84 and P/S of 6.7, reflecting high growth expectations.
Outlook is positive driven by robust merchant demand and cross-border expansion, though risks include execution of acquisitions and competitive pressures. Analysts are unanimously bullish with a $38 consensus target, near the current price. Stock investors should monitor earnings consistency and integration success for sustained upside.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →